albendazole has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalilzadeh, A | 1 |
| Wangoo, KT | 1 |
| Morris, DL | 1 |
| Pourgholami, MH | 1 |
1 other study available for albendazole and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
Topics: Albendazole; Apoptosis; Base Sequence; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell | 2007 |